Hacker News new | ask | show | jobs
by Scoundreller 2537 days ago
1. The consumers aren’t really choosing, their prescribers are, with a lot of friction required to change against their initial decision.

2. While they still had the patent on the regular tamsulosin formulation, they stopped making it. Effectively forcing everyone onto the XR formulation unless they wanted to change molecules entirely.

The data showed little difference as I recall in terms of effectiveness because the half life was long enough to take once daily, regardless of formulation.